However, a separate and compelling body of evidence has shown that in the unique microenvironment of the bone, Wnt5a secreted by osteoblasts acts via ROR2 to suppress canonical Wnt/β-catenin signalling, thereby inducing a state of dormancy in disseminated tumour cells [82]. The gene discussed is ROR2; the disease is neoplasm.